Skip to content
Cart
Sampling fee?

The sample collection fee is a fixed cost that refers to the visit to the clinic where you submit your sample. The fee is not affected by how many tests you have ordered, but varies depending on the order value:

  • For order values under SEK 350, the sampling fee is SEK 129.
  • For order values between SEK 350 and SEK 1000, the fee is SEK 59.
Free sampling fee

For purchases over 1000 SEK, the sampling fee is included.

Give a health check as a Christmas gift 🎁 Get 10 % discount on everything with code JUL10
Testmottagningen logo
en
sv
Testmottagningen logo
Search blood tests or MRI scans
EVM

Glandular fever IgM

EBV antibodies IgM

EBV IgM antibodies are essential for the body's defense against glandular fever. IgM antibodies are rapidly produced in both new and ongoing EBV infections. They mark an active immune response and can identify an infection in the early stages by their presence in the blood.

Give a health check as a Christmas gift – Get 10% with the code JUL10 at Testmottagningen.se.

Read more

Contents

Antibodies glandular fever IgM

EBV antibodies IgM are immunoglobulins of the IgM type that the body produces as a direct response to an initial or ongoing infection in glandular fever or mononucleosis. These antibodies are part of the body's immediate immune response to fight the viral infection.

When does the body start producing IgM antibodies against glandular fever?

In the initial stage of glandular fever, which is caused by the Epstein-Barr virus, the body starts the production of IgM antibodies as part of the immune system to fight the viral infection. The presence of these IgM antibodies in the blood can be used as an indication to identify glandular fever. These IgM antibodies are usually detectable during the first weeks of infection and signal an active and ongoing immune response to EBV.

How is glandular fever spread?

Glandular fever is transmitted primarily through saliva and can be transmitted through kissing, sharing drink containers or other forms of close contact with a person infected with the virus. Transmission of the virus is most common during the initial phase of the disease, but persons who have undergone an EBV infection may continue to shed the virus and be infectious for a longer period. Generally speaking, (EBV) is very widespread globally and most people will have experienced an infection by adulthood. An estimated 90-95% of the world's population carries EBV, which means that they have been infected at some point in their lives.

Analysis of EBV antibodies IgM

Analyses for EBV IgM antibodies are carried out with a blood sample that is analyzed to detect the presence of IgM antibodies. The presence of these antibodies gives a positive test result, indicating an ongoing or recent EBV infection. Positive results for EBV antibodies IgM indicate an active immune response against the virus and can be used to diagnose an acute EBV infection.